Retina-Vitreous
2017 , Vol 25 , Num 2
Muhtemel Sertraline Bağlı Santral Seroz Retinopati
1İnönü Üniversitesi Tıp Fakültesi Göz Hastalıkları Anabilim Dalı, Malatya2İnönü Üniversitesi Tıp Fakültesi Ruh Hastalıkları Anabilim Dalı, Malatya A 36 year-old male patient who developed central serous retinopathy (CSR) presumed to result from intake of sertraline hydrochloride (100 mg per day) during one year.
A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fundus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes.
Keywords :